To achieve a consistently high level of income, with capital growth.
Name | % Net Assets |
---|---|
Vodafone Group | 5.1% |
GLAXOSMITHKLINE | 5.0% |
Astrazeneca | 5.0% |
Unilever | 4.9% |
British American Tobacco | 4.6% |
BP | 4.2% |
Royal Dutch Shell B | 4.1% |
Centrica | 3.9% |
BT group | 3.7% |
BG Group | 3.4% |
Key | % Net Assets |
---|---|
Vodafone Group | 5.1% |
GLAXOSMITHKLINE | 5.0% |
Astrazeneca | 5.0% |
Unilever | 4.9% |
Other | 80% |
Date | 22-Sep-2010 |
---|---|
NAV | 199.95p |
Currency | GBP |
Change | 0.86p |
% | 0.43% |
YTD change | 199.95p |
YTD % | n/a |
Fund Inception | n/a |
---|---|
Fund Manager | Daniel Roberts |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £250 |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research